Cervical sample collection

Pap tests have been used since the 1950s to screen cervical cancer with success, but they have also presented many limitations. Developed in the 1990s, liquid-based cytology (LBC) today brings improvements to laboratories, doctors and patients—in every step of the process, from collection to results.1  

Why a liquid-based Pap test? »

Placeholder

BD SurePath liquid-based Pap test

The BD SurePath liquid-based Pap Test is the liquid-based cytology test from BD. Offering proprietary features and benefits, the test provides advantages over conventional Pap smears and other LBC tests.

Placeholder

BD Onclarity HPV Assay

BD Onclarity™ HPV Assay offers genotyping for HPV primary screening, co-testing, and cytology primary with ASCUS reflex screening paradigms.

References
  1. Nance KV. Evolution of Pap testing at a community hospital: a ten year experience. Diagn Cytopathol. 2007:35(3):148-153.

This site uses cookies. If you click accept cookies then all cookies will be written. Please review our cookies policy and configure your cookies for your experience.